litlas
Log inCreate account

David J. Lockhart

Active 1986–2025

56
Papers
31,842
Citations
54
h-index
56
i10-index

Citations

Citations per year for David J. Lockhart1950: 1 citations1982: 1 citations1983: 1 citations1986: 1 citations1987: 6 citations1988: 9 citations1989: 12 citations1991: 19 citations1992: 5 citations1993: 11 citations1994: 7 citations1995: 7 citations1996: 15 citations1997: 52 citations1998: 137 citations1999: 307 citations2000: 451 citations2001: 727 citations2002: 806 citations2003: 758 citations2004: 732 citations2005: 626 citations2006: 650 citations2007: 570 citations2008: 465 citations2009: 477 citations2010: 381 citations2011: 350 citations2012: 297 citations2013: 250 citations2014: 237 citations2015: 207 citations2016: 183 citations2017: 141 citations2018: 163 citations2019: 431 citations2020: 444 citations2021: 320 citations2022: 249 citations2023: 182 citations2024: 279 citations2025: 152 citations2026: 7 citations1951–1981: no citations, so these years are not shown1984–1985: no citations, so these years are not shown1990: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,204 citing papers, 39.3% of this breakdownUnited Kingdom: 961 citing papers, 7.3% of this breakdownGermany: 855 citing papers, 6.5% of this breakdownChina: 677 citing papers, 5.1% of this breakdownCanada: 541 citing papers, 4.1% of this breakdownFrance: 500 citing papers, 3.8% of this breakdownJapan: 440 citing papers, 3.3% of this breakdownItaly: 380 citing papers, 2.9% of this breakdownSwitzerland: 312 citing papers, 2.4% of this breakdownAustralia: 287 citing papers, 2.2% of this breakdownSpain: 281 citing papers, 2.1% of this breakdownNetherlands: 230 citing papers, 1.7% of this breakdown
0%39.3%Other 19.3%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology65.8%
  • Medicine18.3%
  • Neuroscience4%
  • Computer Science3.7%
  • Agricultural and Biological Sciences1.9%
  • Chemistry1.4%
  • Other4.9%

Topics

  • Gene expression and cancer classification7%
  • Bioinformatics and Genomic Networks5.1%
  • Fungal and yeast genetics research3.4%
  • Genomics and Chromatin Dynamics2.8%
  • Endoplasmic Reticulum Stress and Disease2.6%
  • Gene Regulatory Network Analysis2.2%
  • Other76.9%

Coauthors

All papers

Open in search
  1. In vivo editing of lung stem cells for durable gene correction in mice

    Authors: Yehui Sun, Sumanta Chatterjee, Xizhen Lian, Zachary Traylor, Sandhya Ramani Sattiraju, Yufen Xiao, Sean A. Dilliard, Yun‐Chieh Sung, Minjeong Kim, Sang M. Lee, Stephen Moore, Xu Wang, Di Zhang, Shiying Wu, Pratima Basak, Jialu Wang, Jing Liu, Rachel J. Mann, David F. LePage, Weihong Jiang, Shadaan Abid, M. Hennig, Anna Martinez, Brandon A. Wustman, David J. Lockhart, Raksha Jain, Ronald A. Conlon, Mitchell L. Drumm, Craig A. Hodges, Daniel J. Siegwart - Science 2024 cited by 161

  2. A small molecule–kinase interaction map for clinical kinase inhibitors

    Authors: Miles A. Fabian, William Biggs, Daniel K. Treiber, Corey E. Atteridge, Mihai Azimioara, Michael G. Benedetti, Todd A. Carter, Pietro Ciceri, Philip T. Edeen, M. Brawner Floyd, Julia M. Ford, Margaret Galvin, Jay Gerlach, Robert M. Grotzfeld, Sanna Herrgård, Darren E. Insko, Michael A. Insko, Andiliy Lai, Jean-Michel Lélias, Shamal A. Mehta, Zdravko V. Milanov, Anne Marie Velasco, Lisa Wodicka, Hitesh Patel, Patrick P. Zarrinkar, David J. Lockhart - Nature Biotechnology 2005 cited by 1,914

  3. Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat

    Authors: Dominique P. Germain, Derralynn Hughes, Kathy Nicholls, Daniel G. Bichet, Roberto Giugliani, William R. Wilcox, Claudio Feliciani, Suma P. Shankar, Fatih Süheyl Ezgü, Hernan Amartino, Drago Bratkovic, Ulla Feldt‐Rasmussen, Khan Nedd, Usama Sharaf El Din, Charles Marques Lourenço, Maryam Banikazemi, Joel Charrow, Majed Dasouki, David N. Finegold, Pilar Giraldo, Özlem Göker-Alpan, Nicola Longo, C. Ronald Scott, Roser Torrá, Ahmad Tuffaha, Ana Jovanović, Stephen Waldek, Seymour Packman, Elizabeth Ludington, Christopher Viereck, John Kirk, Julie Yu, Elfrida R. Benjamin, Franklin K. Johnson, David J. Lockhart, Nina Skuban, Jeff Castelli, Jay Barth, Carrolee Barlow, Raphael Schiffmann - New England Journal of Medicine 2016 cited by 556

  4. Functional Characterization of the S. cerevisiae Genome by Gene Deletion and Parallel Analysis

    Authors: Elizabeth A. Winzeler, Daniel Shoemaker, Anna Astromoff, Hong Liang, Keith M. Anderson, Bruno André, Rhonda Bangham, Rocí­o Benito, Jef D. Boeke, Howard Bussey, Angela Chu, Carla J. Connelly, Karen Davis, Fred S. Dietrich, Sally Dow, Mohamed El Bakkoury, Françoise Foury, Stephen Friend, Erik Gentalen, Guri Giaever, Johannes H. Hegemann, Ted Jones, Michael T. Laub, Hong Liao, Nicole Liebundguth, David J. Lockhart, Anca Lucau‐Danila, Marc Lussier, Nasiha M’Rabet, P Ménard, Michael Mittmann, Chai Pai, Corinne Rebischung, José Luis Revuelta, Linda Riles, Christopher J. Roberts, Petra Ross‐Macdonald, Bart Scherens, M Snyder, Sharon Sookhai-Mahadeo, Reginald Storms, Steeve Véronneau, Marleen Voet, Guido Volckaert, Teresa R. Ward, Robert Wysocki, Grace S. Yen, Kexin Yu, Katja Zimmermann, Peter Philippsen, Mark Johnston, Ronald W. Davis - Science 1999 cited by 4,043

  5. Functional and Genomic Analyses Reveal an Essential Coordination between the Unfolded Protein Response and ER-Associated Degradation

    Authors: Kevin Travers, Christopher K. Patil, Lisa Wodicka, David J. Lockhart, Jonathan S. Weissman, Peter Walter - Cell 2000 cited by 2,021

  6. Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

    Authors: Derralynn Hughes, Kathy Nicholls, Suma P. Shankar, Gere Sunder–Plassmann, David M. Koeller, Khan Nedd, Gerard Vockley, Takashi Hamazaki, Robin Lachmann, Toya Ohashi, Iacopo Olivotto, Norio Sakai, Patrick Deegan, David Dimmock, François Eyskens, Dominique P. Germain, Özlem Göker-Alpan, É. Hachulla, Ana Jovanović, Charles Marques Lourenço, Ichiei Narita, Mark Thomas, William R. Wilcox, Daniel G. Bichet, Raphael Schiffmann, Elizabeth Ludington, Christopher Viereck, John Kirk, Julie Yu, Franklin K. Johnson, Pol Boudes, Elfrida R. Benjamin, David J. Lockhart, Carrolee Barlow, Nina Skuban, Jeffrey P. Castelli, Jay Barth, Ulla Feldt‐Rasmussen - Journal of Medical Genetics 2016 cited by 386

  7. Genomics, gene expression and DNA arrays

    Authors: David J. Lockhart, Elizabeth A. Winzeler - Nature 2000 cited by 2,064

  8. The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat

    Authors: Elfrida R. Benjamin, Maria Cecilia Della Valle, Xiaoyang Wu, Evan Katz, Farhana Pruthi, Sarah Bond, Benjamin Bronfin, Hadis Williams, Julie Yu, Daniel G. Bichet, Dominique P. Germain, Roberto Giugliani, Derralynn Hughes, Raphael Schiffmann, William R. Wilcox, Robert J. Desnick, John Kirk, Jay Barth, Carrolee Barlow, Kenneth J. Valenzano, Jeff Castelli, David J. Lockhart - Genetics in Medicine 2016 cited by 209

  9. Expression monitoring by hybridization to high-density oligonucleotide arrays

    Authors: David J. Lockhart, Helin Dong, Michael C. Byrne, Maximillian T. Follettie, Michael V. Gallo, Mark S. Chee, Michael Mittmann, Chunwei Wang, Michiko Kobayashi, Heidi Norton, Eugene L. Brown - Nature Biotechnology 1996 cited by 2,850

  10. Effects of environmental enrichment on gene expression in the brain

    Authors: Claire Rampon, Cecilia Jiang, Helin Dong, Ya‐Ping Tang, David J. Lockhart, Peter G. Schultz, Joe Z. Tsien, Yinghe Hu - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 618

  11. Accessing Genetic Information with High-Density DNA Arrays

    Authors: Mark S. Chee, Robert Yang, Earl Hubbell, Anthony Berno, Xiaohua Huang, David Stern, J. Winkler, David J. Lockhart, Macdonald Morris, Stephen P. A. Fodor - Science 1996 cited by 1,503

  12. Lysosomal Dysfunction in a Mouse Model of Sandhoff Disease Leads to Accumulation of Ganglioside-Bound Amyloid-β Peptide

    Authors: Serene Keilani, Yi Lun, Anthony C. Stevens, Hadis Williams, Eric R. Sjoberg, Richie Khanna, Kenneth J. Valenzano, Frédéric Checler, Joseph D. Buxbaum, Katsuhiko Yanagisawa, David J. Lockhart, Brandon A. Wustman, Sam Gandy - Journal of Neuroscience 2012 cited by 104

  13. Exploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase Inhibitors

    Authors: Nathanael S. Gray, Lisa Wodicka, A.M.W.H. Thunnissen, Thea Norman, Soojin Kwon, F. Hernán Espinoza, David O. Morgan, Georjana Barnes, Sophie Leclerc, Laurent Meijer, Sung‐Hou Kim, David J. Lockhart, Peter G. Schultz - Science 1998 cited by 809

  14. Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases

    Authors: Todd A. Carter, Lisa Wodicka, Neil P. Shah, Anne Marie Velasco, Miles A. Fabian, Daniel K. Treiber, Zdravko V. Milanov, Corey E. Atteridge, William Biggs, Philip T. Edeen, M. Brawner Floyd, Julia M. Ford, Robert M. Grotzfeld, Sanna Herrgård, Darren E. Insko, Shamal A. Mehta, Hitesh Patel, William Pao, Charles L. Sawyers, Harold Varmus, Patrick P. Zarrinkar, David J. Lockhart - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 555

  15. Elevated gene expression levels distinguish human from non-human primate brains

    Authors: Mario Cáceres, Joël Lachuer, Matthew A. Zapala, John C. Redmond, Lili C. Kudo, Daniel H. Geschwind, David J. Lockhart, Todd M. Preuss, Carrolee Barlow - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 499

  16. The Pharmacological Chaperone 1-Deoxygalactonojirimycin Reduces Tissue Globotriaosylceramide Levels in a Mouse Model of Fabry Disease

    Authors: Richie Khanna, Rebecca Soska, Yi Lun, Jessie Feng, Michelle Frascella, Brandy Young, Nastry Brignol, Lee Pellegrino, Sheela Sitaraman, Robert J. Desnick, Elfrida R. Benjamin, David J. Lockhart, Kenneth J. Valenzano - Molecular Therapy 2009 cited by 140

  17. A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy

    Authors: Franziska Richter, Sheila M. Fleming, Melanie B. Watson, Vincent Lemesre, Lee Pellegrino, Brian Ranes, Chunni Zhu, Farzad Mortazavi, Caitlin Mulligan, Pedrom C. Sioshansi, Sindalana Hean, Krystal De La Rosa, Richie Khanna, John J. Flanagan, David J. Lockhart, Brandon A. Wustman, Sean W. Clark, Marie‐Françoise Chesselet - Neurotherapeutics 2014 cited by 107

  18. A Genome-Wide Transcriptional Analysis of the Mitotic Cell Cycle

    Authors: Raymond J. Cho, Michael J. Campbell, Elizabeth A. Winzeler, Lars M. Steinmetz, Andrew Conway, Lisa Wodicka, Tyra G. Wolfsberg, Andrei Gabrielian, David Landsman, David J. Lockhart, Ronald W. Davis - Molecular Cell 1998 cited by 2,076

  19. Transcriptional regulation and function during the human cell cycle

    Authors: Raymond J. Cho, Mingxia Huang, Michael J. Campbell, Helin Dong, Lars M. Steinmetz, Lisa M. Sapinoso, Garret M. Hampton, Stephen J. Elledge, Ronald W. Davis, David J. Lockhart - Nature Genetics 2001 cited by 468

  20. Tuning a Three-Component Reaction For Trapping Kinase Substrate Complexes

    Authors: Alexander V. Statsuk, Dustin J. Maly, Markus A. Seeliger, Miles A. Fabian, William Biggs, David J. Lockhart, Patrick P. Zarrinkar, John Kuriyan, Kevan M. Shokat - Journal of the American Chemical Society 2008 cited by 75

  21. High density synthetic oligonucleotide arrays

    Authors: Robert J. Lipshutz, Stephen P. A. Fodor, T Gingeras, David J. Lockhart - Nature Genetics 1999 cited by 2,220

  22. Replication Dynamics of the Yeast Genome

    Authors: M. K. Raghuraman, Elizabeth A. Winzeler, David Collingwood, Sonia Y. Hunt, Lisa Wodicka, Andrew Conway, David J. Lockhart, Ronald W. Davis, Bonita J. Brewer, Walton L. Fangman - Science 2001 cited by 814

  23. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice

    Authors: Iiris Hovatta, Richard Tennant, Robert Helton, Robert A. Marr, Oded Singer, Jeffrey M. Redwine, Julie A. Ellison, Eric E. Schadt, Inder M. Verma, David J. Lockhart, Carrolee Barlow - Nature 2005 cited by 490

  24. The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β‐glucosidase

    Authors: Richie Khanna, Elfrida R. Benjamin, Lee Pellegrino, Adriane Schilling, Brigitte Rigat, Rebecca Soska, Helia Nafar, Brian Ranes, Jessie Feng, Yi Lun, Allan Powe, David J. Palling, Brandon A. Wustman, Raphael Schiffmann, Don J. Mahuran, David J. Lockhart, Kenneth J. Valenzano - FEBS Journal 2010 cited by 158